Detecting cardiac involvement in sarcoidosis: A call for prospective studies of newer imaging techniques

European Respiratory Journal

Volumn 29, Issue 2, 2007, Pages 418-422

  Pandya, C ^a   Brunken, R C ^a   Tchou, P ^a   Schoenhagen, P ^a   Culver, D A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cardiac arrhythmias; Granulomatosis; Imaging; Magnetic resonance imaging; Positron emission tomography; Sarcoidosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; LEFLUNOMIDE; METHOTREXATE; MEXILETINE; PREDNISONE; RUBIDIUM 82; SOTALOL; VERAPAMIL;

ADULT; ANGIOSARCOMA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DEFIBRILLATION; DIAGNOSTIC ACCURACY; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; GRANULOMATOUS INFLAMMATION; HEART MUSCLE PERFUSION; HEART RIGHT ATRIUM; HEART SARCOIDOSIS; HEART VENTRICLE TACHYCARDIA; HUMAN; INTERMETHOD COMPARISON; LYMPHADENOPATHY; MAINTENANCE THERAPY; MEDIASTINUM DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SARCOIDOSIS; SUPERIOR CAVA VEIN;

CARDIOMYOPATHIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; SARCOIDOSIS;

EID: 33846927026     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00076406     Document Type: Article

References (14)

1. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997; 336: 1224-1234.
2. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58: 1204-1211.
3. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88: 1006-1010.
4. Shimada T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001; 110: 520-527.
5. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005; 45: 1683-1690.
6. Tadamura E, Yamamuro M, Kubo S, et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. Am J Roentgenol 2005; 185: 110-115.
7. Nazarian S, Roguin A, Zviman MM, et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation 2006; 114: 1277-1284.
8. 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 2004; 45: 1989-1998.
9. 18F-FDG PET. J Nucl Med 2003; 44: 1030-1036.
10. Kinney EL, Caldwell JW. Do thallium myocardial perfusion scan abnormalities predict survival in sarcoid patients without cardiac symptoms? Angiology 1990; 41: 573-576.
11. Vignaux O, Dhote R, Duboc D, et al. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr 2002; 26: 762-767.
12. Hyodo E, Hozumi T, Takemoto Y, et al. Early detection of cardiac involvement in patients with sarcoidosis by a non-invasive method with ultrasonic tissue characterisation. Heart 2004; 90: 1275-1280.
13. Kaminaga T, Takeshita T, Yamauchi T, Kawamura H, Yasuda M. The role of iodine-123-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid scintigraphy in the detection of local myocardial involvement of sarcoidosis. Int J Cardiol 2004; 94: 99-103.
14. 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 234-235.